.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Federal Trade Commission
Colorcon
Johnson and Johnson
Baxter
Chinese Patent Office
Julphar
Mallinckrodt
Argus Health
Fuji

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021228

« Back to Dashboard

NDA 021228 describes DETROL LA, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from eight suppliers. There are three patents protecting this drug and one Paragraph IV challenge. Additional details are available on the DETROL LA profile page.

The generic ingredient in DETROL LA is tolterodine tartrate. There are twenty-three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the tolterodine tartrate profile page.

Summary for 021228

Tradename:1
Applicant:1
Ingredient:1
Patents:3
Therapeutic Class:Genitourinary Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 021228

Medical Subject Heading (MeSH) Categories for 021228

Suppliers and Packaging for NDA: 021228

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228 NDA Pharmacia and Upjohn Company LLC 0009-5190 0009-5190-04 100 BLISTER PACK in 1 CARTON (0009-5190-04) > 1 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK
DETROL LA tolterodine tartrate CAPSULE, EXTENDED RELEASE;ORAL 021228 NDA Pharmacia and Upjohn Company LLC 0009-5190 0009-5190-01 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0009-5190-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, EXTENDED RELEASE;ORALStrength2MG
Approval Date:Dec 22, 2000TE:ABRLD:Yes
Patent:► SubscribePatent Expiration:May 11, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:Feb 26, 2020Product Flag?Substance Flag?Delist Request?Y
Patent:► SubscribePatent Expiration:May 11, 2020Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 021228

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And UpjohnDETROL LAtolterodine tartrateCAPSULE, EXTENDED RELEASE;ORAL021228-001Dec 22, 2000► Subscribe► Subscribe
Pharmacia And UpjohnDETROL LAtolterodine tartrateCAPSULE, EXTENDED RELEASE;ORAL021228-002Dec 22, 2000► Subscribe► Subscribe
Pharmacia And UpjohnDETROL LAtolterodine tartrateCAPSULE, EXTENDED RELEASE;ORAL021228-001Dec 22, 2000► Subscribe► Subscribe
Pharmacia And UpjohnDETROL LAtolterodine tartrateCAPSULE, EXTENDED RELEASE;ORAL021228-002Dec 22, 2000► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
UBS
US Army
Teva
Moodys
Chubb
Deloitte
Farmers Insurance
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot